ABX Pentra Micro ALBUMIN 2 CP, Serum/Plasma, REF 1300032563 The device is intended for use in conjunction with certain materials to measure a variety of analytes.
Published July 4, 2018 · Recall initiated: April 26, 2018
Summary
FDA records medical device Class II recall Z-2286-2018, published July 4, 2018 and initiated April 26, 2018. Recalling firm: Horiba Instruments, Inc dba Horiba Medical; Status: Terminated; Reported quantity: 686 devices (233 devices US, 453 devices OUS); Lot: All lot numbers; Software Version(s): Application versions below (V5.14 & V2.12) for Pentra 400 and Versions below (V1.07) for Pentra C400. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
When the ABX Pentra Micro ALBUMIN 2 CP (ALBT2) Reagent 2 is sampled and dispensed immediately after an ABX Pentra Creatinine 120 CP (CREA3) Reagent 2 dispense, the final result of the microalbumin may be elevated more than 10%. This increase may affect serum, plasma and urine sample types.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Horiba Instruments, Inc dba Horiba Medical
- Distributor
- Worldwide Distribution: US (nationwide) and to countries of: Bulgaria, Burma, Cameroon, Djibouti, France, Gabon, Germany, Italy, Lebanon, Mali, Mauritania, Poland, Portugal, Romania, Saudi Arabia, South Africa and Thailand.
- Lot
- All lot numbers; Software Version(s): Application versions below (V5.14 & V2.12) for Pentra 400 and Versions below (V1.07) for Pentra C400
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDACS-7, Model No. A4C1July 4, 2018
- FDAArtis Q.zen floor, Material no. 10848353, for angiography and whole body radiographic/fluoroscopic procedures.July 4, 2018
- FDAABX PENTRA Magnesium RTU Reagent, Part No. A11A01646 Product Usage: ABX PENTRA Magnesium RTU reagent withOctober 1, 2014
- FDADevice Name: ABX PENTRA ML Model/Part #(s): A11A01652 Lot/Serial #(s): N/A Software Version(s): All versionsMarch 19, 2014
- FDAABX PENTRA Multical. ABX PENTRA N Control. ABX PENTRA P Control. The ABX PENTRA 400 and PC200 are benchtopMarch 12, 2014
- FDAABX PENTRA N Control, Model No. A11A01653 The ABX PENTRA N Control is for use in quality control by monitoringFebruary 12, 2014
Questions about this recall
Was ABX Pentra Micro ALBUMIN 2 CP, Serum/Plasma, REF 1300032563 The device is intended for use in conjunction with certain materials to measure a variety of analytes. recalled?
Yes. FDA published recall Z-2286-2018 on July 4, 2018. Reported hazard: When the ABX Pentra Micro ALBUMIN 2 CP (ALBT2) Reagent 2 is sampled and dispensed immediately after an ABX Pentra Creatinine 120 CP (CREA3) Reagent 2 dispense, the final result of the microalbumin may be elevated more than 10%. This increase may affect serum, plasma and urine sample types.
What should I do if I have this product?
Voluntary: Firm initiated · Letter